Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potential as an oral delivery system, promoting intestinal absorption in the lymphatic circulation which plays a role in disseminating metastatic cancer cells and infectious agents throughout the body. SLN features can be exploited for the oral delivery of theranostics. Therefore, the aim of this work was to design and characterise self-assembled lipid nanoparticles (SALNs) to encapsulate and stabilise iron oxide nanoparticles non-covalently coated with heparin (Fe@hepa) as a model of a theranostic tool. SALNs were characterised for physico-chemical properties (particle size, surface charge, encapsulation efficiency, in vitro stability, and heparin...
Background: Application of superparamagnetic iron oxide nanoparticles SPIOs) as the contrast agent h...
Nanoparticle drug delivery vehicles can be used for in vivo delivery of a variety of bioactive molec...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...
Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potent...
Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potent...
Solid Lipid Nanoparticles (SLN) have been proposed for the oral delivery of drugs with poor oral bio...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Novel liposome-nanoparticle assemblies (LNAs) provide a biologically inspired route for designing mu...
Iron (Fe) loaded solid lipid nanoparticles (SLN's) were formulated using stearic acid and iron absor...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Chemical and enzymatic barriers in the gastrointestinal (GI) tract hamper the oral delivery of many ...
To date, the potential of sophorolipids (an important class of glycolipids) has been exploited solel...
Enhancing oral bioavailability of hydrophilic drugs by encapsulation in lipid-based nanocarriers, in...
Khaled Mohamed Hosny,1,2 Zainy Mohammed Banjar,3 Amani H Hariri,4 Ali Habiballah Hassan5 1Department...
Background: Application of superparamagnetic iron oxide nanoparticles SPIOs) as the contrast agent h...
Nanoparticle drug delivery vehicles can be used for in vivo delivery of a variety of bioactive molec...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...
Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potent...
Recently, solid lipid nanoparticles (SLNs) have attracted increasing attention owing to their potent...
Solid Lipid Nanoparticles (SLN) have been proposed for the oral delivery of drugs with poor oral bio...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Novel liposome-nanoparticle assemblies (LNAs) provide a biologically inspired route for designing mu...
Iron (Fe) loaded solid lipid nanoparticles (SLN's) were formulated using stearic acid and iron absor...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Chemical and enzymatic barriers in the gastrointestinal (GI) tract hamper the oral delivery of many ...
To date, the potential of sophorolipids (an important class of glycolipids) has been exploited solel...
Enhancing oral bioavailability of hydrophilic drugs by encapsulation in lipid-based nanocarriers, in...
Khaled Mohamed Hosny,1,2 Zainy Mohammed Banjar,3 Amani H Hariri,4 Ali Habiballah Hassan5 1Department...
Background: Application of superparamagnetic iron oxide nanoparticles SPIOs) as the contrast agent h...
Nanoparticle drug delivery vehicles can be used for in vivo delivery of a variety of bioactive molec...
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemoth...